Evidence map›Paper›PMID 27507269›Full record

ArticleClinical and experimental otorhinolaryngology2017

Effect of

Ertugrul Erhan, Suat Terzi, Metin Celiker, Oguzhan Yarali, Murat Cankaya, Ferda Keskin Cimen, Ismail Malkoc, Bahadir Suleyman

Open access · goldAbstract read
In one paragraph

Article in Clinical and experimental otorhinolaryngology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
3.2field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 1 country.

Ertugrul ErhanDepartment of Otorhinolaryngology, Faculty of Medicine, Erzincan University, Erzincan, Turkey.
Suat TerziDepartment of Otorhinolaryngology, Faculty of Medicine, Recep Tayyip Erdogan University, Rize, Turkey.
Metin CelikerDepartment of Otorhinolaryngology, Rize Education and Research Hospital, Rize, Turkey.
Oguzhan YaraliDepartment of Medical Genetics, Erzurum Training and Research Hospital, Erzurum, Turkey.
Murat CankayaDepartment of Biology, Faculty of Arts and Sciences, Erzincan University, Erzincan, Turkey.
Ferda Keskin CimenDepartment of Pathology, Mengucek Gazi Education and Research Hospital, Erzincan, Turkey.
Ismail MalkocDepartment of Anatomy, Faculty of Medicine, Ataturk University, Erzurum, Turkey.
Bahadir SuleymanDepartment of Pharmacology, Faculty of Medicine, Erzincan University, Erzincan, Turkey.
Erzincan University · TRAtatürk University · TRErzurum Regional Training and Research Hospital · TRRecep Tayyip Erdoğan University · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesThe objective of this study is to investigate and evaluate the effect of

methodsExperimental animals were divided into a healthy group (HG), a HRE+MTX (HREM) group, HRE group (HREG), and a control group that received MTX (MTXG). The HREM and HREG groups of rats was administered 50 mg/kg HRE, while the MTXG and HG groups were given an equal volume distilled water with gavage. Then, the HREM and MTXG rat groups were given oral MTX at a dose of 5 mg/kg 1 hour after HRE and distilled water was administered. This procedure was repeated for 1 month. At the end of this period, all of the animals were sacrificed with a high dose of anesthesia. Then, the amounts of malondialdehyde (MDA) and total glutathione (tGSH) were determined in the removed oropharyngeal tissues. Interleukin-1β (IL-1β) and tumor necrosis factor-α (TNF-α) gene expressions were measured, and all the tissues were studied histopathologically.

resultsThe amount of MDA was significantly increased in the MTXG group compared to the HREM, HREG, and HG groups (

conclusionHRE protected oropharyngeal oxidative damage induced by MTX. As an inexpensive and natural product, HRE has important advantages in the prevention of oropharyngeal damage induced by MTX.

Indexed as

Gene ExpressionHippophaeMethotrexateOral MucositisRatRhamnoides

Identifiers

PMID27507269
PMCPMC5426393
OpenAlexW2515338348

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.